Juventus vs AC Milan

AC Milan to win · Match Winner

Declined after researchCandidate · not a published position

Football · Serie A - Italy · Starts 2026-09-06 18:45 UTC

NOT AN OFFICIAL GLINTARY POSITION

This candidate was researched and did not become a published position. Nothing here was ever on the Board, in the Ledger or on X. Researched, assessed on merit and not published. Most candidates are meant to end here. The engine records this decision as PASS, which means the candidate passed through without a position.

Decision

Outcome: Declined after research
Decided: Sep 6 · 01:30 UTC
Main reason: Evidence grade below the lockable set (and 1 more)

Gates that did not pass

UncertaintyEvidence grade below the lockable setFailed
Adversarial reviewAdversarial review found a blocking objectionFailed

Full gate trace (9 gates)Every gate in order, with its outcome and the reason code in words.

Event integrityReal, identified, pre-match fixture inside the lock windowPassed
EvidenceMaterial claims supported by enough distinct sourcesPassed
PriceRecorded price clears the minimum qualifying oddsPassed
Price sourcePrice attributable to an identified source (global reference only)Passed
FreshnessPrice, evidence and personnel information within the age limitsPassed
UncertaintyEvidence grade below the lockable setFailed
Adversarial reviewAdversarial review found a blocking objectionFailed
DuplicationNo conflicting positionPassed
PresentationPresentation compliantPassed

Research

Evidence grade CAdversarial review · Blocking

Juventus vs AC Milan: Market Discrepancy and Squad Asymmetry Assessment

A headline price of 4.000 at pointsbetau provides a nominal 4.66 percent edge against a 3.822 fair price and a 3.600 62-operator median, ostensibly supported by reports of seven Juventus absences. However, the thesis is fundamentally undermined by a single-sample outlier quote and severe factual anomalies in the squad intelligence.

Primary case

Juventus has seven players confirmed out through injury, including Kenan Yildiz who faces three months out with a fractured metatarsal and Andrea Cambiaso who was injured against Parma (CL-cebd8677-7c2, CL-c7f77642-3cb, CL-3732f42c-364).
AC Milan enters the match with zero reported injuries or suspensions and has scored 9 goals across their last 5 matches, while Juventus conceded 2 goals in their last 5 matches (CL-e43422e3-bdd, sports_data).
The best observed price of 4.000 at pointsbetau clears the 3.96 acceptable price hurdle with an estimated edge of 4.66 percent over the fair price of 3.822.

Major uncertainty

The best observed price of 4.000 from pointsbetau appears to be an isolated, unconfirmed outlier against a 62-operator median of 3.600 with zero historical movement samples recorded, compounded by severe factual anomalies in the underlying intelligence claims.

Market context

The best observed price is 4.000 from pointsbetau in Australia, sitting above the acceptable threshold of 3.96.
The reference price is 3.600 across 62 operators, with a three-way proportional de-vigged fair price of 3.822 and an overround of 6.16 percent.
Market dispersion stands at 11.11 percent across the 62 tracked operators.
Price movement is unrecorded due to only a single observation sample, leaving opening price and trajectory unknown.

What the price requires

Requires the target outcome to beat the 25.00 percent implied probability of 4.000 and the 26.16 percent de-vigged fair price benchmark (3.822).
Requires the pointsbetau 4.000 line to be executable and stable rather than an erroneous quote that will correct downward toward the 3.600 62-book median.

Technical detailsCandidate and scan identifiers, policy version, raw timestamps.

Candidate IDCAND-20260906-edb06168

Scan IDRUN-20260906-995a6a71

Event IDEV-20260906-0c564db0ce78

Scan summary: Open the scan
Policy version: v1.2
Board day: 2026-09-06
Screened: 2026-09-06 01:21 UTC
Research completed: 2026-09-06 01:26 UTC
Decided: 2026-09-06 01:30 UTC

Decision

Research

Juventus vs AC Milan: Market Discrepancy and Squad Asymmetry Assessment

Adversarial review

Why it entered research